Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Sebastian

Showing results (61-70 of 183) with videos related to

Pageof 19
Sort By:
Orphanet Journal of Rare Diseases|October 26, 2022
Correction to: Short-term safety results from compassionate use of risdiplam in patients with spinal muscular atrophy in GermanyAndreas Hahn, René Günther, Albert Ludolph, et al.
Lung Cancer (Amsterdam, Netherlands)|June 10, 2008
TA-MUC1 epitope in non-small cell lung cancerAndreas Kuemmel, Kristjan Single, Fernando Bittinger, et al.
Cancers|September 14, 2024
Correlation of Immunomodulatory Cytokines with Tumor Volume and Cerebrospinal Fluid in Vestibular Schwannoma PatientsAnna-Louisa Becker, Leila Scholle, Clara Helene Klause, et al.
Plos One|August 4, 2017
Human leucocyte antigen (HLA-DR) gene expression is reduced in sepsis and correlates with impaired TNFα response: A diagnostic tool for immunosuppression?Martin Sebastian Winkler, Anne Rissiek, Marion Priefler, et al.
Clinical Lung Cancer|September 11, 2022
Study Design and Rationale for the PACE-LUNG Trial: A Multicenter, Single-Arm, Phase II Clinical Trial Evaluating the Efficacy of Additional Chemotherapy for Patients with EGFRm NSCLC with the Continued Presence of Plasma ctDNA EGFRm at Week 3 After Start of Osimertinib First-Line TreatmentFabian Acker, Lukas Aguinarte, Friederike Althoff, et al.
Molecular Biology Reports|May 16, 2019
Myositis in Lewis rats induced by the superantigen Staphylococcal enterotoxin AAlexander Emmer, Abimbola Abobarin-Adeagbo, Andreas Posa, et al.
Future Oncology (London, England)|December 12, 2025
A phase III placebo-controlled study of eftilagimod alfa plus pembrolizumab and chemotherapy in metastatic non-small cell lung cancerKenneth O'Byrne, Emilio Esteban, Cheen Leng Lee, et al.
Lung Cancer (Amsterdam, Netherlands)|October 24, 2013
A randomized, double-blind, placebo-controlled phase 2 study of tigatuzumab (CS-1008) in combination with carboplatin/paclitaxel in patients with chemotherapy-naïve metastatic/unresectable non-small cell lung cancerMartin Reck, Maciej Krzakowski, Ewa Chmielowska, et al.
Current Oncology (Toronto, Ont.)|April 21, 2022
Pulmonary Resection after Radiosurgery and Neoadjuvant Immunochemotherapy for NSCLC Patients with Synchronous Brain Metastasis-A Case Series of Three PatientsAgnes Koch, Stefan Sponholz, Stephan Trainer, et al.
Targeted Oncology|February 28, 2022
Prevalence of Epidermal Growth Factor Receptor Exon 20 Insertion Mutations in Non-small-Cell Lung Cancer in Europe: A Pragmatic Literature Review and Meta-analysisSuzy Van Sanden, Molly Murton, Anna Bobrowska, et al.
Pageof 19

Showing results (61-70 of 183) with videos related to

Sort By:
Pageof 19
Orphanet Journal of Rare Diseases|October 26, 2022
Correction to: Short-term safety results from compassionate use of risdiplam in patients with spinal muscular atrophy in GermanyAndreas Hahn, René Günther, Albert Ludolph, et al.
Lung Cancer (Amsterdam, Netherlands)|June 10, 2008
TA-MUC1 epitope in non-small cell lung cancerAndreas Kuemmel, Kristjan Single, Fernando Bittinger, et al.
Cancers|September 14, 2024
Correlation of Immunomodulatory Cytokines with Tumor Volume and Cerebrospinal Fluid in Vestibular Schwannoma PatientsAnna-Louisa Becker, Leila Scholle, Clara Helene Klause, et al.
Plos One|August 4, 2017
Human leucocyte antigen (HLA-DR) gene expression is reduced in sepsis and correlates with impaired TNFα response: A diagnostic tool for immunosuppression?Martin Sebastian Winkler, Anne Rissiek, Marion Priefler, et al.
Clinical Lung Cancer|September 11, 2022
Study Design and Rationale for the PACE-LUNG Trial: A Multicenter, Single-Arm, Phase II Clinical Trial Evaluating the Efficacy of Additional Chemotherapy for Patients with EGFRm NSCLC with the Continued Presence of Plasma ctDNA EGFRm at Week 3 After Start of Osimertinib First-Line TreatmentFabian Acker, Lukas Aguinarte, Friederike Althoff, et al.
Molecular Biology Reports|May 16, 2019
Myositis in Lewis rats induced by the superantigen Staphylococcal enterotoxin AAlexander Emmer, Abimbola Abobarin-Adeagbo, Andreas Posa, et al.
Future Oncology (London, England)|December 12, 2025
A phase III placebo-controlled study of eftilagimod alfa plus pembrolizumab and chemotherapy in metastatic non-small cell lung cancerKenneth O'Byrne, Emilio Esteban, Cheen Leng Lee, et al.
Lung Cancer (Amsterdam, Netherlands)|October 24, 2013
A randomized, double-blind, placebo-controlled phase 2 study of tigatuzumab (CS-1008) in combination with carboplatin/paclitaxel in patients with chemotherapy-naïve metastatic/unresectable non-small cell lung cancerMartin Reck, Maciej Krzakowski, Ewa Chmielowska, et al.
Current Oncology (Toronto, Ont.)|April 21, 2022
Pulmonary Resection after Radiosurgery and Neoadjuvant Immunochemotherapy for NSCLC Patients with Synchronous Brain Metastasis-A Case Series of Three PatientsAgnes Koch, Stefan Sponholz, Stephan Trainer, et al.
Targeted Oncology|February 28, 2022
Prevalence of Epidermal Growth Factor Receptor Exon 20 Insertion Mutations in Non-small-Cell Lung Cancer in Europe: A Pragmatic Literature Review and Meta-analysisSuzy Van Sanden, Molly Murton, Anna Bobrowska, et al.
Pageof 19